{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:34:32Z","timestamp":1787589272319,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20795"],"award-info":[{"award-number":["20795"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20795"],"award-info":[{"award-number":["20795"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20795"],"award-info":[{"award-number":["20795"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although adenosine and its analogues have been assessed in the past as potential drug candidates due to the important role of adenosine in physiology, only little is known about their absorption following oral administration. In this work, we have studied the oral absorption and disposition pathways of cordycepin, an adenosine analogue. <jats:italic>In vitro<\/jats:italic> biopharmaceutical properties and <jats:italic>in vivo<\/jats:italic> oral absorption and disposition of cordycepin were assessed in rats. Despite the fact that numerous studies showed efficacy following oral dosing of cordycepin, we found that intact cordycepin was not absorbed following oral administration to rats. However, 3\u2032-deoxyinosine, a metabolite of cordycepin previously considered to be inactive, was absorbed into the systemic blood circulation. Further investigation was performed to study the conversion of 3\u2032-deoxyinosine to cordycepin 5\u2032-triphosphate <jats:italic>in vitro<\/jats:italic> using macrophage-like RAW264.7 cells. It demonstrated that cordycepin 5\u2032-triphosphate, the active metabolite of cordycepin, can be formed not only from cordycepin, but also from 3\u2032-deoxyinosine. The novel nucleoside rescue metabolic pathway proposed in this study could be responsible for therapeutic effects of adenosine and other analogues of adenosine following oral administration. These findings may have importance in understanding the physiology and pathophysiology associated with adenosine, as well as drug discovery and development utilising adenosine analogues.<\/jats:p>","DOI":"10.1038\/s41598-019-52254-x","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T11:08:43Z","timestamp":1572520123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A novel nucleoside rescue metabolic pathway may be responsible for therapeutic effect of orally administered cordycepin"],"prefix":"10.1038","volume":"9","author":[{"given":"Jong Bong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masar","family":"Radhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj D.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarir","family":"Sarmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atheer","family":"Zgair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Adrower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Ortori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-9474","authenticated-orcid":false,"given":"David A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-9271","authenticated-orcid":false,"given":"Peter M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-0085","authenticated-orcid":false,"given":"Cornelia H.","family":"de Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-0933","authenticated-orcid":false,"given":"Pavel","family":"Gershkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"issue":"2","key":"52254_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0955-2863(94)00019-I","volume":"6","author":"JD Carver","year":"1995","unstructured":"Carver, J. D. & Walker, W. A. The Role of Nucleotides in Human-Nutrition. J Nutr Biochem 6(2), 58\u201372, https:\/\/doi.org\/10.1016\/0955-2863(94)00019-I (1995).","journal-title":"J Nutr Biochem"},{"issue":"6","key":"52254_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jcin.2014.02.009","volume":"7","author":"J Layland","year":"2014","unstructured":"Layland, J., Carrick, D., Lee, M., Oldroyd, K. & Berry, C. Adenosine Physiology, Pharmacology, and Clinical Applications. Jacc-Cardiovasc Inte 7(6), 581\u2013591, https:\/\/doi.org\/10.1016\/j.jcin.2014.02.009 (2014).","journal-title":"Jacc-Cardiovasc Inte"},{"key":"52254_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(97)00256-7","volume":"79","author":"JC Shryock","year":"1997","unstructured":"Shryock, J. C. & Belardinelli, L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 79, 2\u201310, https:\/\/doi.org\/10.1016\/S0002-9149(97)00256-7 (1997).","journal-title":"Am J Cardiol"},{"issue":"2","key":"52254_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2165\/00003495-199958020-00002","volume":"58","author":"HJ Agteresch","year":"1999","unstructured":"Agteresch, H. J., Dagnelie, P. C., van den Berg, J. W. & Wilson, J. H. Adenosine triphosphate: established and potential clinical applications. Drugs 58(2), 211\u2013232, https:\/\/doi.org\/10.2165\/00003495-199958020-00002 (1999).","journal-title":"Drugs"},{"issue":"3","key":"52254_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1734-1140(11)70573-4","volume":"63","author":"M Samsel","year":"2011","unstructured":"Samsel, M. & Dzierzbicka, K. Therapeutic potential of adenosine analogues and conjugates. Pharmacol Rep 63(3), 601\u2013617, https:\/\/doi.org\/10.1016\/S1734-1140(11)70573-4 (2011).","journal-title":"Pharmacol Rep"},{"issue":"2","key":"52254_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/edrv.20.2.0361","volume":"20","author":"L Aguilar-Bryan","year":"1999","unstructured":"Aguilar-Bryan, L. & Bryan, J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocrine reviews 20(2), 101\u2013135, https:\/\/doi.org\/10.1210\/edrv.20.2.0361 (1999).","journal-title":"Endocrine reviews"},{"issue":"8","key":"52254_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","volume":"185","author":"M Leist","year":"1997","unstructured":"Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. The Journal of experimental medicine 185(8), 1481\u20131486, https:\/\/doi.org\/10.1084\/jem.185.8.1481 (1997).","journal-title":"The Journal of experimental medicine"},{"issue":"1","key":"52254_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature reviews Cancer 2(1), 48\u201358, https:\/\/doi.org\/10.1038\/nrc706 (2002).","journal-title":"Nature reviews Cancer"},{"issue":"15","key":"52254_CR9","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1016\/j.bmcl.2009.05.027","volume":"19","author":"SJ Mantell","year":"2009","unstructured":"Mantell, S. J. et al. SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data. Bioorg Med Chem Lett 19(15), 4471\u20134475, https:\/\/doi.org\/10.1016\/j.bmcl.2009.05.027 (2009).","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"52254_CR10","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/j.1476-5381.1995.tb16398.x","volume":"116","author":"Mathot","year":"1995","unstructured":"Mathot et al. analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo. Br J Pharmacol 116(3), 1957\u20131964, https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16398.x (1995).","journal-title":"Br J Pharmacol"},{"issue":"1","key":"52254_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1472-8206.1992.tb00088.x","volume":"6","author":"F Fauvelle","year":"1992","unstructured":"Fauvelle, F. et al. Pharmacokinetics of vidarabine in the treatment of polyarteritis nodosa. Fundam Clin Pharmacol 6(1), 11\u201315, https:\/\/doi.org\/10.1111\/j.1472-8206.1992.tb00088.x (1992).","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"52254_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jn\/114.4.753","volume":"114","author":"LM Salati","year":"1984","unstructured":"Salati, L. M., Gross, C. J. & Henderson, L. M. Savaiano DA Absorption and Metabolism of Adenine, Adenosine-5\u2032-Monophosphate, Adenosine and Hypoxanthine by the Isolated Vascularly Perfused Rat Small-Intestine. J Nutr 114(4), 753\u2013760, https:\/\/doi.org\/10.1093\/jn\/114.4.753 (1984).","journal-title":"J Nutr"},{"issue":"5","key":"52254_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/clpt.1990.86","volume":"47","author":"NR Hartman","year":"1990","unstructured":"Hartman, N. R. et al. Pharmacokinetics of 2\u2032,3\u2032-dideoxyadenosine and 2\u2032,3\u2032-dideoxyinosine in patients with severe human immunodeficiency virus infection. Clin Pharmacol Ther 47(5), 647\u2013654, https:\/\/doi.org\/10.1038\/clpt.1990.86 (1990).","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"52254_CR14","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","volume":"48","author":"DB Olsen","year":"2004","unstructured":"Olsen, D. B. et al. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Antimicrob Agents Chemother 48(10), 3944\u20133953, https:\/\/doi.org\/10.1128\/AAC.48.10.3944-3953.2004 (2004).","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"52254_CR15","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1021\/jm0102755","volume":"45","author":"L Cappellacci","year":"2002","unstructured":"Cappellacci, L. et al. Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1\u2032-C-methyl adenosine analogues. J Med Chem 45(6), 1196\u20131202, https:\/\/doi.org\/10.1021\/jm0102755 (2002).","journal-title":"J Med Chem"},{"issue":"3","key":"52254_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bmcl.2008.12.031","volume":"19","author":"W Shen","year":"2009","unstructured":"Shen, W. et al. Design and synthesis of vidarabine prodrugs as antiviral agents. Bioorg Med Chem Lett 19(3), 792\u2013796, https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.031 (2009).","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"52254_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15257770802581757","volume":"28","author":"W Shen","year":"2009","unstructured":"Shen, W. et al. 5\u2032-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine. Nucleosides Nucleotides Nucleic Acids 28(1), 43\u201355, https:\/\/doi.org\/10.1080\/15257770802581757 (2009).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"5","key":"52254_CR18","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.jpba.2006.01.046","volume":"41","author":"SP Li","year":"2006","unstructured":"Li, S. P., Yang, F. Q. & Tsim, K. W. Quality control of Cordyceps sinensis, a valued traditional Chinese medicine. J Pharm Biomed Anal 41(5), 1571\u20131584, https:\/\/doi.org\/10.1016\/j.jpba.2006.01.046 (2006).","journal-title":"J Pharm Biomed Anal"},{"issue":"12","key":"52254_CR19","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1261\/rna.032391.112","volume":"18","author":"A Kondrashov","year":"2012","unstructured":"Kondrashov, A. et al. Inhibition of polyadenylation reduces inflammatory gene induction. RNA 18(12), 2236\u20132250, https:\/\/doi.org\/10.1261\/rna.032391.112 (2012).","journal-title":"RNA"},{"issue":"4","key":"52254_CR20","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1074\/jbc.M109.071159","volume":"285","author":"YY Wong","year":"2010","unstructured":"Wong, Y. Y. et al. Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 285(4), 2610\u20132621, https:\/\/doi.org\/10.1074\/jbc.M109.071159 (2010).","journal-title":"J Biol Chem"},{"issue":"7","key":"52254_CR21","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.18632\/oncotarget.14661","volume":"8","author":"JC Joo","year":"2017","unstructured":"Joo, J. C. et al. Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma. Oncotarget 8(7), 12211\u201312224, https:\/\/doi.org\/10.18632\/oncotarget.14661 (2017).","journal-title":"Oncotarget"},{"key":"52254_CR22","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-017-0795-0","author":"JB Lee","year":"2017","unstructured":"Lee, J. B. et al. Development of Cordycepin Formulations for Preclinical and Clinical Studies. AAPS Pharm Sci Tech. https:\/\/doi.org\/10.1208\/s12249-017-0795-0 (2017).","journal-title":"AAPS Pharm Sci Tech."},{"key":"52254_CR23","doi-asserted-by":"publisher","first-page":"423869","DOI":"10.1155\/2015\/423869","volume":"2015","author":"DW Zhang","year":"2015","unstructured":"Zhang, D. W., Deng, H., Qi, W., Zhao, G. Y. & Cao, X. R. Osteoprotective effect of cordycepin on estrogen deficiency-induced osteoporosis in vitro and in vivo. Biomed Res Int 2015, 423869, https:\/\/doi.org\/10.1155\/2015\/423869 (2015).","journal-title":"Biomed Res Int"},{"issue":"3","key":"52254_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1254\/jphs.08308FP","volume":"109","author":"KJ Won","year":"2009","unstructured":"Won, K. J. et al. Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats. J Pharmacol Sci 109(3), 403\u2013412, https:\/\/doi.org\/10.1254\/jphs.08308FP (2009).","journal-title":"J Pharmacol Sci"},{"issue":"1\u20133","key":"52254_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejphar.2013.05.049","volume":"714","author":"ZL Cai","year":"2013","unstructured":"Cai, Z. L. et al. Effects of cordycepin on Y-maze learning task in mice. Eur J Pharmacol 714(1\u20133), 249\u2013253, https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.049 (2013).","journal-title":"Eur J Pharmacol"},{"key":"52254_CR26","doi-asserted-by":"publisher","first-page":"840134","DOI":"10.1155\/2013\/840134","volume":"2013","author":"Z Hu","year":"2013","unstructured":"Hu, Z. et al. Cordycepin Increases Nonrapid Eye Movement Sleep via Adenosine Receptors in Rats. Evid Based Complement Alternat Med 2013, 840134, https:\/\/doi.org\/10.1155\/2013\/840134 (2013).","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"52254_CR27","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1111\/j.1440-1681.2004.04108.x","volume":"31","author":"N Yoshikawa","year":"2004","unstructured":"Yoshikawa, N. et al. Antitumour activity of cordycepin in mice. Clin Exp Pharmacol Physiol 31(2), S51\u201353, https:\/\/doi.org\/10.1111\/j.1440-1681.2004.04108.x (2004).","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1-3","key":"52254_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2011.04.052","volume":"664","author":"Z Cheng","year":"2011","unstructured":"Cheng, Z. et al. Cordycepin protects against cerebral ischemia\/reperfusion injury in vivo and in vitro. Eur J Pharmacol 664(1-3), 20\u201328, https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.052 (2011).","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"52254_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/10286020.2011.575364","volume":"13","author":"Y Sun","year":"2011","unstructured":"Sun, Y., Wang, Y. H., Qu, K. & Zhu, H. B. Beneficial effects of cordycepin on metabolic profiles of liver and plasma from hyperlipidemic hamsters. J Asian Nat Prod Res 13(6), 534\u2013546, https:\/\/doi.org\/10.1080\/10286020.2011.575364 (2011).","journal-title":"J Asian Nat Prod Res"},{"issue":"12","key":"52254_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.exger.2012.09.003","volume":"47","author":"T Ramesh","year":"2012","unstructured":"Ramesh, T. et al. Cordycepin (3\u2032-deoxyadenosine) attenuates age-related oxidative stress and ameliorates antioxidant capacity in rats. Exp Gerontol 47(12), 979\u2013987, https:\/\/doi.org\/10.1016\/j.exger.2012.09.003 (2012).","journal-title":"Exp Gerontol"},{"issue":"5","key":"52254_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nutres.2015.04.011","volume":"35","author":"L Ma","year":"2015","unstructured":"Ma, L., Zhang, S. & Du, M. Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice. Nutr Res 35(5), 431\u2013439, https:\/\/doi.org\/10.1016\/j.nutres.2015.04.011 (2015).","journal-title":"Nutr Res"},{"issue":"9\u201310","key":"52254_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2119\/molmed.2011.00032","volume":"17","author":"H Kim","year":"2011","unstructured":"Kim, H., Naura, A. S., Errami, Y., Ju, J. & Boulares, A. H. Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP. Mol Med 17(9\u201310), 893\u2013900, https:\/\/doi.org\/10.2119\/molmed.2011.00032 (2011).","journal-title":"Mol Med"},{"issue":"2","key":"52254_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.canlet.2016.04.001","volume":"376","author":"Y Du","year":"2016","unstructured":"Du, Y., Yu, J., Du, L., Tang, J. & Feng, W. H. Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin. Cancer Lett 376(2), 240\u2013248, https:\/\/doi.org\/10.1016\/j.canlet.2016.04.001 (2016).","journal-title":"Cancer Lett"},{"key":"52254_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41140-1","volume":"9","author":"S Ashraf","year":"2019","unstructured":"Ashraf, S. et al. The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis. Sci Rep 9, 4696, https:\/\/doi.org\/10.1038\/s41598-019-41140-1 (2019).","journal-title":"Sci Rep"},{"issue":"2","key":"52254_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ejmech.2008.05.013","volume":"44","author":"HP Wei","year":"2009","unstructured":"Wei, H. P. et al. Synthesis and pharmacokinetic evaluation of novel N-acyl-cordycepin derivatives with a normal alkyl chain. Eur J Med Chem 44(2), 665\u2013669, https:\/\/doi.org\/10.1016\/j.ejmech.2008.05.013 (2009).","journal-title":"Eur J Med Chem"},{"issue":"8","key":"52254_CR36","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1021\/jf100269g","volume":"58","author":"YJ Tsai","year":"2010","unstructured":"Tsai, Y. J., Lin, L. C. & Tsai, T. H. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J Agric Food Chem 58(8), 4638\u20134643, https:\/\/doi.org\/10.1021\/jf100269g (2010).","journal-title":"J Agric Food Chem"},{"issue":"3","key":"52254_CR37","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s10753-014-0068-y","volume":"38","author":"Z Tianzhu","year":"2015","unstructured":"Tianzhu, Z., Shihai, Y. & Juan, D. The effects of cordycepin on ovalbumin-induced allergic inflammation by strengthening Treg response and suppressing Th17 responses in ovalbumin-sensitized mice. Inflammation 38(3), 1036\u20131043, https:\/\/doi.org\/10.1007\/s10753-014-0068-y (2015).","journal-title":"Inflammation"},{"issue":"4","key":"52254_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/nu8040231","volume":"8","author":"Ce Dou","year":"2016","unstructured":"Dou, C. et al. Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation. Nutrients 8 (4), https:\/\/doi.org\/10.3390\/nu8040231 (2016)","journal-title":"Nutrients"},{"issue":"5607","key":"52254_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/267178a0","volume":"267","author":"KM Rose","year":"1977","unstructured":"Rose, K. M., Bell, L. E. & Jacob, S. T. Specific inhibition of chromatin-associated poly(A) synthesis in vitro by cordycepin 5\u2032-triphosphate. Nature 267(5607), 178\u2013180, https:\/\/doi.org\/10.1038\/267178a0 (1977).","journal-title":"Nature"},{"issue":"12","key":"52254_CR40","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/cdd.2011.63","volume":"18","author":"M Kitamura","year":"2011","unstructured":"Kitamura, M. et al. Aberrant, differential and bidirectional regulation of the unfolded protein response towards cell survival by 3\u2032-deoxyadenosine. Cell death and differentiation 18(12), 1876\u20131888, https:\/\/doi.org\/10.1038\/cdd.2011.63 (2011).","journal-title":"Cell death and differentiation"},{"issue":"3","key":"52254_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0006-2952(99)00325-1","volume":"59","author":"EN Kodama","year":"2000","unstructured":"Kodama, E. N., McCaffrey, R. P., Yusa, K. & Mitsuya, H. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem Pharmacol 59(3), 273\u2013281, https:\/\/doi.org\/10.1016\/S0006-2952(99)00325-1 (2000).","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"52254_CR42","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1128\/AAC.42.6.1424","volume":"42","author":"AM Sugar","year":"1998","unstructured":"Sugar, A. M. & McCaffrey, R. P. Antifungal activity of 3\u2032-deoxyadenosine (cordycepin). Antimicrob Agents Chemother 42(6), 1424\u20131427 (1998).","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"52254_CR43","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1086\/496896","volume":"192","author":"ME Rottenberg","year":"2005","unstructured":"Rottenberg, M. E. et al. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model. J Infect Dis 192(9), 1658\u20131665, https:\/\/doi.org\/10.1086\/496896 (2005).","journal-title":"J Infect Dis"},{"key":"52254_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2018.07.022","volume":"286","author":"JB Lee","year":"2018","unstructured":"Lee, J. B. et al. Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system. Journal of controlled release: official journal of the Controlled Release Society 286, 10\u201319, https:\/\/doi.org\/10.1016\/j.jconrel.2018.07.022 (2018).","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"issue":"2","key":"52254_CR45","doi-asserted-by":"publisher","first-page":"e00121","DOI":"10.1002\/prp2.121","volume":"3","author":"G Li","year":"2015","unstructured":"Li, G., Nakagome, I., Hirono, S., Itoh, T. & Fujiwara, R. Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances. Pharmacology research &. perspectives 3(2), e00121, https:\/\/doi.org\/10.1002\/prp2.121 (2015).","journal-title":"perspectives"},{"issue":"1","key":"52254_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/taap.1997.8264","volume":"147","author":"LE Rodman","year":"1997","unstructured":"Rodman, L. E. et al. Toxicity of cordycepin in combination with the adenosine deaminase inhibitor 2\u2032-deoxycoformycin in beagle dogs. Toxicol Appl Pharmacol 147(1), 39\u201345, https:\/\/doi.org\/10.1006\/taap.1997.8264 (1997).","journal-title":"Toxicol Appl Pharmacol"},{"key":"52254_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874126601004010002","volume":"4","author":"N Fotaki","year":"2010","unstructured":"Fotaki, N. & Vertzoni, M. Biorelevant Dissolution Methods and Their Applications in In Vitro-In Vivo Correlations for Oral Formulations. The Open Drug Delivery. Journal 4, 2\u201313, https:\/\/doi.org\/10.2174\/1874126601004010002 (2010).","journal-title":"Journal"},{"key":"52254_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2016.12.027","volume":"114","author":"JB Lee","year":"2017","unstructured":"Lee, J. B. et al. Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays. Eur J Pharm Biopharm 114, 38\u201342, https:\/\/doi.org\/10.1016\/j.ejpb.2016.12.027 (2017).","journal-title":"Eur J Pharm Biopharm"},{"key":"52254_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.trsl.2016.03.015","volume":"174","author":"DA Taha","year":"2016","unstructured":"Taha, D. A. et al. The role of acid-base imbalance in statin-induced myotoxicity. Transl Res 174, 140\u2013160 e114, https:\/\/doi.org\/10.1016\/j.trsl.2016.03.015 (2016).","journal-title":"Transl Res"},{"issue":"2","key":"52254_CR50","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.xphs.2018.09.025","volume":"108","author":"Jong Bong Lee","year":"2019","unstructured":"Lee, J. B. et al. Quantitative prediction of oral bioavailability of a lipophilic antineoplastic drug bexarotene administered in lipidic formulation using a combined in vitro lipolysis\/microsomal metabolism approach. Journal of pharmaceutical sciences. https:\/\/doi.org\/10.1016\/j.xphs.2018.09.025 (2018)","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"52254_CR51","first-page":"1350","volume":"27","author":"RS Obach","year":"1999","unstructured":"Obach, R. S. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug metabolism and disposition: the biological fate of chemicals 27(11), 1350\u20131359 (1999).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"10","key":"52254_CR52","first-page":"1316","volume":"29","author":"Y Naritomi","year":"2001","unstructured":"Naritomi, Y. et al. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug metabolism and disposition: the biological fate of chemicals 29(10), 1316\u20131324 (2001).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"52254_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchromb.2016.11.024","volume":"1040","author":"JB Lee","year":"2017","unstructured":"Lee, J. B. et al. Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 1040, 73\u201380, https:\/\/doi.org\/10.1016\/j.jchromb.2016.11.024 (2017).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"52254_CR54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1568026013394886","volume":"1","author":"H Bohets","year":"2001","unstructured":"Bohets, H. et al. Strategies for absorption screening in drug discovery and development. Curr Top Med Chem 1(5), 367\u2013383, https:\/\/doi.org\/10.2174\/1568026013394886 (2001).","journal-title":"Curr Top Med Chem"},{"key":"52254_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbiotec.2014.12.019","volume":"205","author":"JB Lee","year":"2015","unstructured":"Lee, J. B. et al. A novel in vitro permeability assay using three-dimensional cell culture system. J Biotechnol 205, 93\u2013100, https:\/\/doi.org\/10.1016\/j.jbiotec.2014.12.019 (2015).","journal-title":"J Biotechnol"},{"issue":"2","key":"52254_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","volume":"2","author":"SP Colgan","year":"2006","unstructured":"Colgan, S. P., Eltzschig, H. K., Eckle, T. & Thompson, L. F. Physiological roles for ecto-5\u2032-nucleotidase (CD73). Purinergic Signal 2(2), 351\u2013360, https:\/\/doi.org\/10.1007\/s11302-005-5302-5 (2006).","journal-title":"Purinergic Signal"},{"issue":"6","key":"52254_CR57","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2.6.875","volume":"2","author":"M Martignoni","year":"2006","unstructured":"Martignoni, M., Groothuis, G. M. & de Kanter, R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2(6), 875\u2013894, https:\/\/doi.org\/10.1517\/17425255.2.6.875 (2006).","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"52254_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF03189670","volume":"20","author":"RA Coulombe Jr.","year":"1995","unstructured":"Coulombe, R. A. Jr., Sharma, R. P. & Huggins, J. W. Pharmacokinetics of the antiviral agent 3-deazaneplanocin A. Eur J Drug Metab Pharmacokinet 20(3), 197\u2013202 (1995).","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"52254_CR59","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.biopha.2017.09.103","volume":"95","author":"J Yang","year":"2017","unstructured":"Yang, J., Li, Y. Z., Hylemon, P. B., Zhang, L. Y. & Zhou, H. P. Cordycepin inhibits LPS-induced inflammatory responses by modulating NOD-Like Receptor Protein 3 inflammasome activation. Biomedicine & pharmacotherapy=Biomedecine & pharmacotherapie 95, 1777\u20131788, https:\/\/doi.org\/10.1016\/j.biopha.2017.09.103 (2017).","journal-title":"Biomedicine & pharmacotherapy=Biomedecine & pharmacotherapie"},{"issue":"2","key":"52254_CR60","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0006-291X(84)90282-1","volume":"123","author":"Y Wataya","year":"1984","unstructured":"Wataya, Y. & Hiraoka, O. 3\u2032-Deoxyinosine as an anti-leishmanial agent: the metabolism and cytotoxic effects of 3\u2032-deoxyinosine in Leishmania tropica promastigotes. Biochem Biophys Res Commun 123(2), 677\u2013683 (1984).","journal-title":"Biochem Biophys Res Commun"},{"key":"52254_CR61","first-page":"69","volume":"15","author":"Y Wataya","year":"1984","unstructured":"Wataya, Y. et al. Anti-parasite activity of nucleoside analogues in Leishmania tropica promastigotes. Nucleic Acids Symp Ser 15, 69\u201371 (1984).","journal-title":"Nucleic Acids Symp Ser"},{"issue":"17","key":"52254_CR62","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1016\/S0021-9258(17)39289-X","volume":"260","author":"SW LaFon","year":"1985","unstructured":"LaFon, S. W., Nelson, D. J., Berens, R. L. & Marr, J. J. Inosine analogs. Their metabolism in mouse L cells and in Leishmania donovani. J Biol Chem 260(17), 9660\u20139665 (1985).","journal-title":"J Biol Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52254-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:15:24Z","timestamp":1671290124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52254-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15760"}}